Table 3:

Differences in GFA between patients with unilateral ISSHL (hearing loss ipsilateral side and contralateral side) and healthy subjectsa

ROIsPatients with Unilateral ISSHLHealthy Controls (n = 20)P Value
Hearing Loss Ipsilateral Side (n = 48)Hearing Loss Contralateral Side (n = 48)
Superior olivary nucleus0.0898 ± 0.01420.0922 ± 0.01630.08993 ± 0.0066.69
Inferior colliculus0.0951 ± 0.00900.0948 ± 0.00670.0939 ± 0.0050.84
Medial geniculate body0.0963 ± 0.01160.0940 ± 0.00980.0979 ± 0.0067.31
Lateral lemniscus0.0951 ± 0.00840.0911 ± 00920.0928 ± 0.0061.07
Anterior limb of internal capsule0.0816 ± 0.00680.0815 ± 0.00710.0865 ± 0.0038.01
Posterior limb of internal capsule0.0984 ± 0.0073c0.0997 ± 0.0051b0.1046 ± 0.0026.001
Heschl0.0829 ± 0.02280.0842 ± 0.01400.0857 ± 0.0078.83
Superior temporal gyrus0.0894 ± 0.00700.0892 ± 0.00790.0920 ± 0.0034.28
Middle temporal gyrus0.0920 ± 0.00570.0907 ± 0.00610.0932 ± 0.0026.20
Inferior temporal gyrus0.0850 ± 0.00840.0850 ± 0.00710.0859 ± 0.0064.89
Anterior corona radiata0.0884 ± 0.00750.0881 ± 0.00760.0941 ± 0.0039.005
Posterior corona radiata0.1084 ± 0.00930.1079 ± 0.00910.1131 ± 0.0071.08
Auditory radiation0.0997 ± 0.00890.0992 ± 0.00930.1015 ± 0.0057.61
Brodmann area 410.0950 ± 0.00740.0960 ± 0.0034.47
Brodmann area 420.0812 ± 0.00850.0831 ± 0.0090.41
  • a Data are mean ± SD.

  • b Compared with the control group, P < .05 after Bonferroni correction.

  • c Compared with the control group, P < .01 after Bonferroni correction.